Thursday, September 30, 2010

Access 20 years of survey methodology for public health researchers

Access 20 years of survey methodology for public health researchers

Read our free virtual issue, Survey Methodology for Public Health
Researchers: Selected Readings from 20 years of Public Opinion
Quarterly. The virtual issue's 18 articles illustrate the range of
survey methods material that can be found in POQ and include conclusions
that are still valid today. Specially chosen by guest editor Floyd J.
Fowler, the articles will be of interest to those who work and research
in public health and health services more broadly.

http://www.oxfordjournals.org/our_journals/poq/collectionspage.html

Tuesday, September 28, 2010

The Lack of Utility of Circulating Biomarkers of Inflammation and Endothelial Dysfunction for Type 2 Diabetes Risk Prediction Among Postmenopausal Women

Arch Intern Med -- The Lack of Utility of Circulating Biomarkers of
Inflammation and Endothelial Dysfunction for Type 2 Diabetes Risk
Prediction Among Postmenopausal Women: The Women's Health Initiative
Observational Study, September 27, 2010, Chao et al.

A study from WHI:
http://archinte.ama-assn.org/cgi/content/full/170/17/1557

Monday, September 27, 2010

Friday, September 24, 2010

Thursday, September 23, 2010

ADDITION: No significant benefit of intensive therapy in diabetes

ADDITION: No significant benefit of intensive therapy in diabetes

September 22, 2010 | Lisa Nainggolan
Stockholm, Sweden - Intensive multifactorial treatment was not significantly better than routine care in a study of 3000 patients with newly diagnosed type 2 diabetes treated by general practitioners, at least in terms of the primary outcome, a composite of first cardiovascular events. Results of the Anglo-Danish-Dutch Study in General Practice of Intensive Treatment and Complication Prevention in Type 2 Diabetic Patients Identified by Screening (ADDITION) trial were reported today at the European Association for the Study of Diabetes (EASD) 2010 Meeting by Dr Simon J Griffin (University of Cambridge, UK).
 
Griffin said the study "was pragmatic and relevant to everyday general practice" and shows that "intensive treatment in people with screen-detected diabetes is feasible" in primary care. The lack of a significant effect of the intensive intervention on the primary end point was likely the result of the great improvements in the routine care of diabetes over the course of the study in the three countries involved, Denmark, the Netherlands, and the UK, he commented.
 
"Even in the routine-care group that did not receive significant additional support, cardiovascular risk factors improved in the five years following detection by screening. Our intervention to promote more intensive treatment was associated with statistically significant but relatively modest differences in prescribed treatment, in levels of risk factors, and in the proportion of patients for whom treatment targets were achieved. These relatively small differences were in turn associated with a nonsignificant 17% relative reduction in the incidence of a composite CV end point over five years," he told meeting attendees.

Important to note also, said Griffin, was the fact that maintaining average glycated hemoglobin (HbA1c) levels of 6.5% in the intensive-treatment arm of the study was not associated with any increased mortality risk. This is seen as particularly important in the wake of the ACCORD results, a trial in which intensive glucose lowering appeared to increase mortality.

Commentators applauded the ADDITION trial, which they noted must have been very difficult to carry out. The invited discussant, Dr William H Herman (University of Michigan, Ann Arbor), explained that all prior studies of this nature have been observational, and this was research that "I personally believed would never be performed." ADDITION demonstrates that primary-care-based stepwise screening for type 2 diabetes "is feasible and identifies patients with substantial levels of cardiovascular risk that is potentially modifiable," said Herman.